The Journal of Immunology, Vol 143, Issue 11 3686-3690, Copyright © 1989 by American Association of Immunologists

ARTICLES

Impaired macrophage activation in vitamin D3 deficiency: differential in vitro effects of 1,25-dihydroxyvitamin D3 on mouse peritoneal macrophage functions

R Gavison and Z Bar-Shavit
Humphrey Center for Experimental Medicine and Cancer Research, Hebrew University, Jerusalem, Israel 91010.

1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) is known to interact in vitro with mononuclear phagocytes. The purpose of this study was to determine the role of the steroid in macrophage activation in vivo. Peritoneal macrophages from normal and vitamin D3-deficient mice were obtained after i.p. injection of activating or eliciting agents. Cells obtained from vitamin D3-deficient mice exhibited defected capabilities to perform anti-tumor activities (cytostasis and cytolysis) and to form oxygen reduction products (H2O2 and O2-). On the other hand, the level of the lysosomal enzyme acid phosphatase was unaffected by vitamin D3 deficiency. In vitro, incubation of macrophages with 1,25(OH)2D3 enhanced their anti-tumor activities, but did not affect the cells' capacity to produce H2O2 and O2-, or acid phosphatase. Our results suggest that 1,25(OH)2D3 is essential for macrophage activation in vivo. However, in vitro, the hormone is only partially capable of affecting the macrophage functions, probably because of the maturation state of the cells.

This article has been cited by other articles:

				R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF]

				C. C. Leung, W. W. Yew, T. Y. K. Chan, C. M. Tam, C. Y. Chan, C. K. Chan, N. Tang, K. C. Chang, and W. S. Law Seasonal pattern of tuberculosis in Hong Kong Int. J. Epidemiol., August 1, 2005; 34(4): 924 - 930. [Abstract] [Full Text] [PDF]

				P. Lips Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications Endocr. Rev., August 1, 2001; 22(4): 477 - 501. [Abstract] [Full Text] [PDF]

				A. Ravid, D. Rocker, A. Machlenkin, C. Rotem, A. Hochman, G. Kessler-Icekson, U. A. Liberman, and R. Koren 1,25-Dihydroxyvitamin D3 Enhances the Susceptibility of Breast Cancer Cells to Doxorubicin-induced Oxidative Damage Cancer Res., February 1, 1999; 59(4): 862 - 867. [Abstract] [Full Text] [PDF]

				C. J. Haug, P. Aukrust, E. Haug, L. Mørkrid, F. Müller, and S. S. Frøland Severe Deficiency of 1,25-Dihydroxyvitamin D3 in Human Immunodeficiency Virus Infection: Association with Immunological Hyperactivity and Only Minor Changes in Calcium Homeostasis J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3832 - 3838. [Abstract] [Full Text]

				M. K. Thomas, D. M. Lloyd-Jones, R. I. Thadhani, A. C. Shaw, D. J. Deraska, B. T. Kitch, E. C. Vamvakas, I. M. Dick, R. L. Prince, and J. S. Finkelstein Hypovitaminosis D in Medical Inpatients N. Engl. J. Med., March 19, 1998; 338(12): 777 - 783. [Abstract] [Full Text] [PDF]